ClinicalTrials.gov
ClinicalTrials.gov Menu

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01779531
Recruitment Status : Unknown
Verified January 2013 by Liao Ning, Guangdong Academy of Medical Sciences.
Recruitment status was:  Not yet recruiting
First Posted : January 30, 2013
Last Update Posted : January 30, 2013
Sponsor:
Collaborators:
Chinese Anti-Cancer Association
Guangzhou General Hospital of Guangzhou Military Command
Guangzhou First People's Hospital
Information provided by (Responsible Party):
Liao Ning, Guangdong Academy of Medical Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2014
  Estimated Study Completion Date : June 2015